Global Lymphoblastic Lymphoma Clinical Trials Market Outlook to 2017: Ken Research

https://www.kenresearch.com/blog/wp-content/uploads/2018/02/Lymphoblastic-Lymphoma.jpg

GlobalData’sclinical trial report, Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2017″ provides an overview of Lymphoblastic Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Lymphoblastic Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData’sproprietary database-Pharma eTrack Clinical trials

Advertisements

Lymphedema Global Clinical Trials Review H2 2017: Ken Research

https://www.kenresearch.com/blog/wp-content/uploads/2018/02/Lymphedema.jpg

GlobalData’sclinical trial report, Lymphedema Global Clinical Trials Review, H2, 2017” provides an overview of Lymphedema clinical trials scenario. This report provides top line data relating to the clinical trials on Lymphedema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ diffe

Indonesia Pharmaceutical Market will be led by Growing Generic Drugs and Bio-pharmaceutical Market: Ken Research

Expansion of product portfolio by major pharmaceutical companies and increase in demand for generic drugs were the key factors driving growth in Indonesia pharmaceutical Market. The report titled “Indonesia Pharmaceutical Market Outlook to 2022 – By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology),… Continue reading Indonesia Pharmaceutical Market will be led by Growing Generic Drugs and Bio-pharmaceutical Market: Ken Research

Lymphangioleiomyomatosis Global Clinical Trials Review H2 2017: Ken Research

https://www.kenresearch.com/blog/wp-content/uploads/2018/02/Lymphangioleiomyomatosis.jpg

GlobalData’sclinical trial report, Lymphangioleiomyomatosis Global Clinical Trials Review, H2, 2017” provides an overview of Lymphangioleiomyomatosis clinical trials scenario. This report provides top line data relating to the clinical trials on Lymphangioleiomyomatosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData’sproprietary database-Pharma eTrack Clini

Global Lyme Disease Clinical Trials Market Research Report: Ken Research

https://www.kenresearch.com/blog/wp-content/uploads/2018/02/Lyme-Disease-Clinical-Trials-Market.jpg

GlobalData’sclinical trial report, Lyme Disease Global Clinical Trials Review, H2, 2017” provides an overview of Lyme Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Lyme Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData’sproprietary database-Pharma eTrack Clinical trials database. Clinical

Clinical Laboratory Market Future Trends Indonesia

https://www.kenresearch.com/blog/wp-content/uploads/2018/02/clinical-laboratory.jpg

Implementation of JKN (National Health Insurance System) by the government, expansion of major laboratory chains, improving margins and technology advancements were the key factors driving growth in Indonesia clinical laboratory Market.

Indonesia healthcare market has shown a positive incline during 2012-2017 but with respect to the expanding population of Indonesia, the market is still underserved especially in the underdeveloped and rural areas as of 2017.

Greater Universal Health Coverage has increased accessibility to healthcare services, leading to a rising number of the population seeking treatment and thereby increasing laboratory testing. The UHC scheme has increased the demand for basic and specialized testing. Since public clinical labs are not equipped with the technology for specialized testing, such tests have been outsourced to private independent labora

Number of Kimia Farma Apotek in Indonesia, Pharmacy Retailers in Indonesia – Ken Research

https://www.kenresearch.com/blog/wp-content/uploads/2018/02/Pharmacy.jpg

Indonesia pharmacy retail market segment (by pharmacies & drugstores and by region), value chain, trends, growth drivers, and competitive landscape of major pharmacy retail companies including Guardian Pharmacy, Kimia Farma, Apotek K-24, A S Watsons Group, and Century Healthcare. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions. The healthcare market in Indonesia was majorly impacted by the implementation of JKN (Indonesian National Health Insurance) as the demand for affordable/primary healthcare services, generic medicines and medical devices increased. Indonesia pharmacy retail market is highly fragmented with organized pharmacy retail chains contributing less than 8% to the revenue share. Major organized chains include Guardian pharmacy, Kimia Farma, Apotek K-24 and AS Watsons Group.

The pharmacy retail market ha